miR-611 promotes the proliferation, migration and invasion of tongue squamous cell carcinoma cells by targeting FOXN3.
Shuai ChenJianyun ZhangLisha SunXuefen LiJiaying BaiHeyu ZhangTie-Jun LiPublished in: Oral diseases (2019)
Our findings suggest that miR-611 is a novel therapeutic target for TSCC.